Advertisement

Food-Based Interventions for Cancer Management: An Ayurvedic Perspective

  • Sanjoy Kumar Pal
Chapter

Abstract

Cancer remains the major cause of mortality and morbidity worldwide. Despite the billions of dollars spent on research each year, recent statistics indicate that overall cancer incidence has not changed significantly in the last half-century. Although modern science has made major strides in understanding cancer and its molecular basis, the knowledge about how to prevent or treat cancer still lags behind. Environmental carcinogenic agents, occupational environments, and dietary habits have been found to be associated with the majority of cancers. Age-adjusted cancer incidence in the Western world is much higher than that of the Eastern world. It is now believed that dietary habits could be one of the major contributing factors in the genesis of cancer. The optimal way to deal with any disease is by prevention, and this is particularly relevant for cancer. It has been observed that individuals consuming relatively large amounts of vegetables and fruits are at a decreased risk of cancer of many organs. Ayurveda, a traditional Indian medicine system, has been successful since ancient times at using natural drugs to prevent or suppress a variety of tumors using various lines of treatment. Ayurvedic texts emphasize ahara, proper diet, as vital for promoting health and well-being. Although this traditional medicine has been around for thousands of years, the scientific community has recently started to pay attention to it. Following Ayurvedic principles a new paradigm for food-based cancer prevention and management can be developed to reduce the burden of this malignant disease.

Keywords

Anticancer Property Gambogic Acid Nigella Sativa Diallyl Disulfide Black Cumin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30Google Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90Google Scholar
  3. 3.
    Chung MY, Lim TG, Lee KW (2013) Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol 19(7):984–993Google Scholar
  4. 4.
    Wang JB, Jiang Y, Liang H, Li P, Xiao HJ, Ji J, Xiang W, Shi JF, Fan YG, Li L, Wang D, Deng SS, Chen WQ, Wei WQ, Qiao YL, Boffetta P (2012) Attributable causes of cancer in China. Ann Oncol 23(11):2983–2989Google Scholar
  5. 5.
    Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25(9):2097–2116Google Scholar
  6. 6.
    Dolara P, Bigagli E, Collins A (2012) Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary. Eur J Nutr 51(7):769–781Google Scholar
  7. 7.
    Syed DN, Chamcheu JC, Mukhtar VM (2013) Pomegranate extracts and cancer prevention: molecular and cellular activities. Anticancer Agents Med Chem 13(8):1149–1161Google Scholar
  8. 8.
    Pal D, Banerjee S, Ghosh AK (2012) Dietary-induced cancer prevention: an expanding research arena of emerging diet related to healthcare system. J Adv Pharm Technol Res 3(1):16–24Google Scholar
  9. 9.
    Balachandran P, Govindarajan R (2005) Cancer – an ayurvedic perspective. Pharmacol Res 51:19–30Google Scholar
  10. 10.
    Patel D, Mansoori A (2012) Cancer – an ayurvedic perspective. IJARPB 2(2):179–195Google Scholar
  11. 11.
    Chopra A, Doiphode VV (2002) Ayurvedic medicine, core concept, therapeutic principles, and current relevance. Complement Alternat Med 86:75–89Google Scholar
  12. 12.
    Murthy KRS (2005) Sushruta Samhita (700 BC). Choukhamba Orientalia, VaranasiGoogle Scholar
  13. 13.
    Sharma PV (1981) Charaka Samhita. Choukhamba Orientalia, VaranasiGoogle Scholar
  14. 14.
    Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222–228Google Scholar
  15. 15.
    Kinzler KW, Vogelstein B (eds) (2002) The genetic basis of human cancer, 2nd edn. McGraw-Hill/Medical Pub., New York, Division, p 5Google Scholar
  16. 16.
    Croce CM (2008) Oncogenes and cancer. N Engl J Med 358(5):502–511Google Scholar
  17. 17.
    Sherr CJ (2004) Principles of tumor suppression. Cell 116(2):235–246Google Scholar
  18. 18.
    Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, Zipursky SL, Darnell J (eds) (2004) Molecular biology of the cell, 5th edn. WH Freeman, New York, p 963Google Scholar
  19. 19.
    Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73–91Google Scholar
  20. 20.
    Flamme I, Frölich T, Risau W (1997) Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173(2):206–210Google Scholar
  21. 21.
    Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: mirage or reality? Nat Med 15(9):1010–1012Google Scholar
  22. 22.
    Matsui W, Wang Q, Barber JP et al (2008) Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 68(1):190–197Google Scholar
  23. 23.
    Henderson BE, Bernstein L, Ross RK et al (2000) Hormones and the etiology of cancer. In: Bast RC, Kufe DW, Pollock RE (eds) Holland-Frei cancer medicine, 5th edn. B. C. Decker, HamiltonGoogle Scholar
  24. 24.
    Sasco AJ, Secretan MB, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45(Suppl 2):S3–S9Google Scholar
  25. 25.
    Biesalski HK, Bueno de Mesquita B, Chesson A, Chytil F, Grimble R, Hermus RJ, Köhrle J, Lotan R, Norpoth K, Pastorino U, Thurnham D (1998) European consensus statement on lung cancer: risk factors and prevention. Lung cancer panel. CA Cancer J Clin 48(3):167–176Google Scholar
  26. 26.
    Singh RH (2002) An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in ayurveda. J Alternat Complement Med 8(5):609–614Google Scholar
  27. 27.
    Thatte U, Dhahanukar S (1991) Ayurveda, the natural alternative. Sci Today 2001:12–18Google Scholar
  28. 28.
    Dash B, Kashyap L (1987) Diagnosis and treatment of Galaganda, Gandamala, apaci, granthi and arbuda. Concept Publishing Company, New DelhiGoogle Scholar
  29. 29.
    Garodia P, Ichikawa H, Malani N, Sethi G, Aggarwal BB (2007) From ancient medicine to modern medicine: ayurvedic concept of health and their role in inflammation and cancer. J Soc Integr Oncol 5(1):25–37Google Scholar
  30. 30.
    Abdulla M, Gruber P (2000) Role of diet modification in cancer prevention. Biofactors 12(1–4):45–51Google Scholar
  31. 31.
    Park S, Bae J, Nam BH, Yoo KY (2008) Aetiology of cancer in Asia. Asian Pac J Cancer Prev 9(3):371–380Google Scholar
  32. 32.
    Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43–68Google Scholar
  33. 33.
    Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74–108Google Scholar
  34. 34.
    Ziegler RG, Hoover RN, Pike MC et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827Google Scholar
  35. 35.
    Kolonel LN, Altshuler D, Henderson BE (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4:519–527Google Scholar
  36. 36.
    Wong AH, Gottesman II, Petronis A (2005) Phenotypic differences in genetically identical organisms: the epigenetic perspective. [Special issue] Hum Mol Genet 14(1):R11–18Google Scholar
  37. 37.
    Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441Google Scholar
  38. 38.
    Cappellani A, Di Vita M, Zanghi A, Cavallaro A, Piccolo G, Veroux M, Berretta M, Malaguarnera M, Canzonieri V, Lo Menzo E (2012) Diet, obesity and breast cancer: an update. Front Biosci (Scholar edition) 4:90–108Google Scholar
  39. 39.
    Key TJ (2011) Fruit and vegetables and cancer risk. Brit J Cancer 104(1):6–11Google Scholar
  40. 40.
    Larsson SC, Wolk A (2007) Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 132(5):1740–1745Google Scholar
  41. 41.
    Ferguson LR (2010) Meat and cancer. Meat Sci 84(2):308–313Google Scholar
  42. 42.
    Zheng W, Lee SA (2009) Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61(4):437–446Google Scholar
  43. 43.
    Rajaram S, Sabate J (2000) Health benefits of a vegetarian diet. Nutrition 16:531–533Google Scholar
  44. 44.
    Sengupta A, Ghosh S, Bhattacharjee S, Das S (2004) Indian food ingredients and cancer prevention – an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pac J Cancer Prev 5(2):126–132Google Scholar
  45. 45.
    Jain MG, Hislop GT, Howe GR, Ghadirian P (1999) Plant foods, antioxidants, and prostate cancer risk: findings from case–control studies in Canada. Nutr Cancer 34:173–184Google Scholar
  46. 46.
    Bishop MJ (1991) Molecular themes in oncogenesis. Cell 64:235–248Google Scholar
  47. 47.
    Hong WK, Sporn MB (1997) Recent advances in chemoprevention of cancer. Science 278:1073–1077Google Scholar
  48. 48.
    Tanaka T, Kohno H, Mori H (2001) Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac J Cancer Prev 3:165–177Google Scholar
  49. 49.
    Shukla Y, Arora A, Taneja P (2003) Antigenotoxic potential of certain dietary constituents. Teratog Carcinog Mutagen 23(Suppl 1):323–335Google Scholar
  50. 50.
    Willett WC, MacMohan B (1984) Diet and cancer – an overview (first of the two parts). N Engl J Med 310:633–638Google Scholar
  51. 51.
    Willett WC, MacMohan B (1984) Diet and cancer – an overview (second of the two parts). N Engl J Med 310:697–703Google Scholar
  52. 52.
    Shukla Y, Pal SK (2004) Dietary cancer chemoprevention: an overview. Int J Hum Genet 4(4):265–276Google Scholar
  53. 53.
    Gerber M (2001) The comprehensive approach to diet: a critical review. J Nutr 131:3051S–3055SGoogle Scholar
  54. 54.
    Wattenberg LW (1997) An overview of chemoprevention: current status and future prospect. Proc Soc Exp Biol Med 216:133–144Google Scholar
  55. 55.
    Hospodar M (2013) The dosha balancing diet. http://www.yogajournal.com/health/646. Accessed 28 November 2013
  56. 56.
    Lad V (1997) Food combination. In: Lad U, Lad V (eds) Ayurveda cooking for self-healing. The Ayurvedic Press, AlbuquerqueGoogle Scholar
  57. 57.
    Park EJ, Pezzuto JM (2002) Botanicals in cancer chemoprevention. Can Metas Rev 21:231–255Google Scholar
  58. 58.
    Block G, Patterson B, Subar A (1992) Fruits, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18:1–29Google Scholar
  59. 59.
    Koutsokera A, Kiagia M, Saif MW, Souliotis K, Syrigos KN (2013) Nutrition habits, physical activity, and lung cancer: an authoritative review. Clin Lung Cancer 14(4):342–350Google Scholar
  60. 60.
    Steinmetz KA, Potter JD (1991) Vegetables, fruits, and cancer. I. Epidemiology. Cancer Causes Control 2:325–357Google Scholar
  61. 61.
    Steinmetz KA, Potter JD (1991) Vegetables, fruits, and cancer. II. Mechanisms. Cancer Causes Control 2:427–442Google Scholar
  62. 62.
    Steinmetz KA, Potter JD (1996) Vegetables, fruits, and cancer prevention: a review. J Am Diet Assoc 96:1027–1039Google Scholar
  63. 63.
    Brenner DE (2000) Multiagent chemoprevention agent combinations. J Cell Biochem 34(Suppl):121–124Google Scholar
  64. 64.
    Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024–1028Google Scholar
  65. 65.
    Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 10:768–680Google Scholar
  66. 66.
    Bajbouj K, Schulze-Luehrmann J, Diermeier S, Amin A, Schneider-Stock R (2012) The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines. BMC Complement Alternat Med 12:69–77Google Scholar
  67. 67.
    Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 4:519–534Google Scholar
  68. 68.
    Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiollo FB, Piantelli M (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87:595–600Google Scholar
  69. 69.
    Dragsted LO, Strube M, Leth T (1997) Dietary levels of plant phenols and other non-nutritive components: could they prevent cancer? Eur J Cancer Prev 6:522–528Google Scholar
  70. 70.
    Zloch Z (1996) The role of dietary plant polyphenols in health maintenance. Cas Lek Cesk 135:84–88Google Scholar
  71. 71.
    Kim DJ, Shin DH, Ahn B, Kang JS, Nam KT, Park CB, Kim CK, Hong JT et al (2003) Chemoprevention of colon cancer by Korean food plant components. Mutat Res 523–524:99–107Google Scholar
  72. 72.
    Talalay P, Fahey JW (2001) Phytochemicals from cruciferous plant protects against cancer by modulating carcinogen metabolism. J Nutr 131:3027S–3033SGoogle Scholar
  73. 73.
    Srivastava B, Shukla Y (1998) Antitumour promoting activity of indole-3-carbinol in mouse skin carcinogenesis. Cancer Lett 134:91–96Google Scholar
  74. 74.
    Hwang ES, Bowen PE (2002) Can the consumption of tomatoes for lycopene reduce cancer risk? Integr Cancer Ther 2:121–132Google Scholar
  75. 75.
    Tan H, Thomas-Ahner J, Grainger E, Wan L, Francis D, Schwartz S, Erdman J, Clinton S, Hsueh-Li T (2010) Tomato-based food products for prostate cancer prevention: what have we learned? Cancer Metastasis Rev 29(3):553–568Google Scholar
  76. 76.
    Hutchins AM, Winham DM, Thompson SV (2012) Phaseolus beans: impact on glycaemic response and chronic disease risk in human subjects. Br J Nutr 108(Suppl 1):S52–S65Google Scholar
  77. 77.
    Magee PJ, Rowland I (2012) Soy products in the management of breast cancer. Curr Opin Clin Nutr Metab Care 15(6):586–591Google Scholar
  78. 78.
    Yang G, Shu XO, Chow WH, Zhang X, Li HL, Ji BT, Cai H, Wu S, Gao YT, Zheng W (2012) Soy food intake and risk of lung cancer: evidence from the Shanghai women’s health study and a meta-analysis. Am J Epidemiol 176(10):846–855Google Scholar
  79. 79.
    Yang WS, Va P, Wong MY, Zhang HL, Xiang YB (2011) Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr 94(6):1575–1583Google Scholar
  80. 80.
    Patel S, Goyal A (2012) Recent developments in mushrooms as anti-cancer therapeutics: a review. Biotech 2(1):1–15Google Scholar
  81. 81.
    Batra P, Sharma AK, Khajuria R (2013) Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. Int J Med Mushrooms 15(2):127–143Google Scholar
  82. 82.
    Baliga MS, Dsouza JJ (2011) Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev 20(3):225–239Google Scholar
  83. 83.
    Baliga MS (2010) Triphala ayurvedic formulation for treating and preventing cancer: a review. J Altern Complement Med 16(12):1301–1308Google Scholar
  84. 84.
    Kaur S, Michael H, Arora S, Härkönen PL, Kumar S (2005) The in vitro cytotoxic and apoptotic activity of Triphala-an Indian herbal drug. J Ethnopharmacol 97(1):15–20Google Scholar
  85. 85.
    Sandhya T, Lathika KM, Pandey BN, Mishra KP (2006) Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett 231(2):206–214Google Scholar
  86. 86.
    Lu K, Chakroborty D, Sarkar C, Lu T, Xie Z, Liu Z, Basu S (2012) Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. PLoS One 7(8):e43934Google Scholar
  87. 87.
    Kim J, Jayaprakasha GK, Patil BS (2013) Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells. Food Funct 4(2):258–265Google Scholar
  88. 88.
    Meiyanto E, Hermawan A, Anindyajati (2012) Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev 13(2):427–436Google Scholar
  89. 89.
    Zhou K, Raffoul JJ (2012) Potential anticancer properties of grape antioxidants. J Oncol 2012:803294Google Scholar
  90. 90.
    Zhao J, Wang J, Chen Y, Agarwal R (1999) Anti-tumor promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two stage initiation promotion protocol and identification of procyanidin B 5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 20:1737–1745Google Scholar
  91. 91.
    He X, Wang Y, Hu H, Zhang Z (2012) In vitro and in vivo antimammary tumor activities and mechanisms of the apple total triterpenoids. J Agric Food Chem 60(37):9430–9436Google Scholar
  92. 92.
    Gerhauser C (2008) Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Med 74(13):1608–1624Google Scholar
  93. 93.
    Baliga MS (2011) Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam). Asian Pac J Cancer Prev 12(1):3–15Google Scholar
  94. 94.
    Arung ET, Shimizu K, Kondo R (2007) Structure-activity relationship of prenyl-substituted polyphenols from Artocarpus heterophyllus as inhibitors of melanin biosynthesis in cultured melanoma cells. Chem Biodivers 4(9):2166–2171Google Scholar
  95. 95.
    García-Rivera D, Delgado R, Bougarne N, Haegeman G, Berghe WV (2011) Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer Lett 305(1):21–31Google Scholar
  96. 96.
    Yu MH, Im HG, Kim HI, Lee IS (2009) Induction of apoptosis by immature plum in human hepatocellular carcinoma. J Med Food 12(3):518–527Google Scholar
  97. 97.
    Bhui K, Tyagi S, Prakash B, Shukla Y (2010) Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. Biofactors 36(6):474–482Google Scholar
  98. 98.
    Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK (2012) Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett 323(1):29–40Google Scholar
  99. 99.
    Nguyen TT, Shaw PN, Parat MO, Hewavitharana AK (2013) Anticancer activity of Carica papaya: a review. Mol Nutr Food Res 57(1):153–164Google Scholar
  100. 100.
    Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, Reliene R (2013) Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog. doi:  10.1002/mc.21995
  101. 101.
    Somasagara RR, Hegde M, Chiruvella KK, Musini A, Choudhary B, Raghavan SC (2012) Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in mice. PLoS One 7(10):e47021Google Scholar
  102. 102.
    Abdelwahab SI, Hassan LE, Abdul Majid AM, Yagi SM, Mohan S, Elhassan Taha MM, Ahmad S, Chuen CS, Narrima P, Rais MM, Syam S, Moharam BA, Hadi AH (2012) Cucurbitacin L 2-O-β-glucoside demonstrates apoptogenesis in colon adenocarcinoma cells (HT-29): involvement of reactive oxygen and nitrogen species regulation. Evid Based Complement Alternat Med 2012:490136Google Scholar
  103. 103.
    Bontempo P, Doto A, Miceli M, Mita L, Benedetti R, Nebbioso A, Veglione M, Rigano D, Cioffi M, Sica V, Molinari AM, Altucci L (2012) Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation. Cell Prolif 45(1):22–31Google Scholar
  104. 104.
    Deneo-Pellegrini H, De Stefani E, Ronco A (1996) Vegetables, fruits, and risk of colorectal cancer: a case–control study from Uruguay. Nutr Cancer 25(3):297–304Google Scholar
  105. 105.
    Kaefer CM, Milner JA (2011) Herbs and spices in cancer prevention and treatment. In: Benzie IFF, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press, Boca RatonGoogle Scholar
  106. 106.
    Lampe JW (2003) Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 78(3 Suppl):579S–583SGoogle Scholar
  107. 107.
    Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE (2006) Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185(4 Suppl):S4–S24Google Scholar
  108. 108.
    Dwivedi V, Shrivastava R, Hussain S, Ganguly C, Bharadwaj M (2011) Comparative anticancer potential of clove (Syzygium aromaticum) – an Indian spice – against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev 12:1989–1993Google Scholar
  109. 109.
    Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P (2008) Potential of spice-derived phytochemicals for cancer prevention. Planta Med 74(13):1560–1569Google Scholar
  110. 110.
    Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75Google Scholar
  111. 111.
    Baumeister P, Reiter M, Harréus U (2012) Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxid Med Cell Longev 2012:902716Google Scholar
  112. 112.
    Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75(4):787–809Google Scholar
  113. 113.
    Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71(10):1397–1421Google Scholar
  114. 114.
    Teiten M, Eifes S, Dicato M, Diederich M (2010) Curcumin – the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins 2:128–162Google Scholar
  115. 115.
    Steward WP, Gescher AJ (2008) Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res 52:1005–1009Google Scholar
  116. 116.
    Baliga MS, Haniadka R, Pereira MM, D’Souza JJ, Pallaty PL, Bhat HP, Popuri S (2011) Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr 51(6):499–523Google Scholar
  117. 117.
    Karna P, Chagani S, Gundala SR, Rida PC, Asif G, Sharma V, Gupta MV, Aneja R (2012) Benefits of whole ginger extract in prostate cancer. Br J Nutr 107(4):473–484Google Scholar
  118. 118.
    Brahmbhatt M, Gundala SR, Asif G, Shamsi SA, Aneja R (2013) Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutr Cancer 65(2):263–272Google Scholar
  119. 119.
    Krell J, Stebbing J (2012) Ginger: the root of cancer therapy? Lancet Oncol 13(3):235–236Google Scholar
  120. 120.
    Liu Y, Whelan RJ, Pattnaik BR, Ludwig K, Subudhi E, Rowland H, Claussen N, Zucker N, Uppal S, Kushner DM, Felder M, Patankar MS, Kapur A (2012) Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLoS One 7(12):e53178Google Scholar
  121. 121.
    Iciek M, Kwiecień I, Włodek L (2009) Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen 50(3):247–265Google Scholar
  122. 122.
    Siegers CP, Steffen B, Robke A, Pentz R (1999) The effects of garlic preparations against human tumour cell proliferation. Phytomedicine 6:7–11Google Scholar
  123. 123.
    Fanelli SL, Castro GD, De-toranzo EG, Castro JA (1998) Mechanisms of the preventive properties of some garlic components in carbon tetrachloride-promoted oxidative stress, diallyl sulphide, diallyl disulphide, allyl mercaptan and allyl methyl sulphide. Res Commun Mol Path 102:163–174Google Scholar
  124. 124.
    National Cancer Institute (2008) Garlic and cancer prevention. http://www.cancer.gov/cancertopics/factsheet/prevention/garlic-and-cancer-prevention. Accessed 14 July 2013
  125. 125.
    Fleischauer AT, Arab L (2001) Garlic and cancer: a critical review of the epidemiologic literature. J Nutr 131(3s):1032S–1040SGoogle Scholar
  126. 126.
    Li H, Li HQ, Wang Y et al (2004) An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chinese Med J 117(8):1155–1160Google Scholar
  127. 127.
    Banerjee S, Panda CK, Das S (2006) Clove (Ayzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis 27:1645–1654Google Scholar
  128. 128.
    Mohamad RH, El-Bastawesy AM, Abdel-Monem MG, Noor AM, Al-Mehdar HA, Sharawy SM, El-Merzabani MM (2011) Antioxidant and anticarcinogenic effects of methanolic extract and volatile oil of fennel seeds (Foeniculum vulgare). J Med Food 14(9):986–1001Google Scholar
  129. 129.
    Singh B, Kale RK (2008) Chemomodulatory action of Foeniculum vulgare (fennel) on skin and forestomach papillomagenesis, enzymes associated with xenobiotic metabolism and antioxidant status in murine model system. Food Chem Toxicol 46(12):3842–3850Google Scholar
  130. 130.
    Khan MA, Chen HC, Tania M, Zhang DZ (2011) Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Altern Med 8(5 Suppl):226–232Google Scholar
  131. 131.
    Hasan TN, Shafi G, Syed NA, Alfawaz MA, Alsaif MA, Munshi A, Lei KY, Alshatwi AA (2013) Methanolic extract of Nigella sativa seed inhibits SiHa human cervical cancer cell proliferation through apoptosis. Nat Prod Commun 8(2):213–216Google Scholar
  132. 132.
    Bhattacharjee B, Vijayasarathy S, Karunakar P, Chatterjee J (2012) Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pac J Cancer Prev 13(11):5605–5611Google Scholar
  133. 133.
    Hong JW, Yang GE, Kim YB, Eom SH, Lew JH, Kang H (2012) Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med 12:237. doi: 10.1186/1472-6882-12-237 Google Scholar
  134. 134.
    Kwon HK, Hwang JS, So JS, Lee CG, Sahoo A, Ryu JH, Jeon WK, Ko BS, Im CR, Lee SH, Park ZY, Im SH (2010) Cinnamon extract induces tumor cell death through inhibition of NFκB and AP1. BMC Cancer 10:392. doi: 10.1186/1471-2407-10-392 Google Scholar
  135. 135.
    Banerjee S, Sharma R, Kale RK, Rao AR (1994) Influence of certain essential oils on carcinogen- metabolizing enzymes and acid-soluble sulfhydryls in mouse liver. Nutr Cancer 21:263–269Google Scholar
  136. 136.
    Pal SK, Shukla Y (2003) Herbal medicine: current status and the future. Asian Pac J Cancer Prev 4:281–288Google Scholar
  137. 137.
    Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O (2010) Cancer prevention with natural compounds. Semin Oncol 37(3):258–281Google Scholar
  138. 138.
    Cravotto G, Boffa L, Genzini L, Garella D (2010) Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther 35:11–48Google Scholar
  139. 139.
    Patel B, Das S, Prakash R, Yasir M (2010) Natural bioactive compound with anticancer potential. Int J Advan Pharm Sci 1:32–41Google Scholar
  140. 140.
    Smit HF, Woerdenbag HJ, Singh RH, Meulenbeld GJ, Labadie RP, Zwaving JH (1995) Ayurvedic herbal drugs with possible cytostatic activity. J Ethnopharmacol 47:75–84Google Scholar
  141. 141.
    Bailey HH, Mukhtar H (2013) Green tea polyphenols and cancer chemoprevention of genitourinary cancer. Am Soc Clin Oncol Educ Book 2013:92–96. doi: 10.1200/EdBook_AM.2013.33.92 Google Scholar
  142. 142.
    Darvesh AS, Bishayee A (2013) Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer 65(3):329–344Google Scholar
  143. 143.
    Graham HN (1992) Green tea composition consumption and polyphenols chemistry. Prev Med 21:334–350Google Scholar
  144. 144.
    Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ (2012) Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4(11):1679–1691Google Scholar
  145. 145.
    Donejko M, Niczyporuk M, Galicka E, Przylipiak A (2013) Anti-cancer properties epigallocatechin-gallate contained in green tea. Postepy Hig Med Dosw (Online) 67:26–34Google Scholar
  146. 146.
    Lee AH, Su D, Pasalich M, Binns CW (2013) Tea consumption reduces ovarian cancer risk. Cancer Epidemiol 37(1):54–59Google Scholar
  147. 147.
    Wang ZH, Gao QY, Fang JY (2012) Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutr Cancer 64(8):1143–1152Google Scholar
  148. 148.
    Zheng P, Zheng HM, Deng XM, Zhang YD (2012) Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies. BMC Gastroenterol 12:165. doi: 10.1186/1471-230X-12-165 Google Scholar
  149. 149.
    Nangia-Makker P, Raz T, Tait L, Shekhar MP, Li H, Balan V, Makker H, Fridman R, Maddipati K, Raz A (2013) Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. Cancer Biol Ther 14(5). http://www.ncbi.nlm.nih.gov/pubmed/23380593
  150. 150.
    Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK (2013) Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Lett 336(2):270–280Google Scholar
  151. 151.
    Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS (2011) Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochem Pharmacol 82(9):1100–1109Google Scholar
  152. 152.
    Srivastava P, Yadav N, Lella R, Schneider A, Jones A, Marlowe T, Lovett G, O’Loughlin K, Minderman H, Gogada R, Chandra D (2012) Neem oil limonoids induces p53-independent apoptosis and autophagy. Carcinogenesis 33(11):2199–2207Google Scholar
  153. 153.
    Paul R, Prasad M, Sah NK (2011) Anticancer biology of Azadirachta indica L (neem): a mini review. Cancer Biol Ther 12(6):467–476Google Scholar
  154. 154.
    Kikuchi T, Ishii K, Noto T, Takahashi A, Tabata K, Suzuki T, Akihisa T (2011) Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of Azadirachta indica (neem). J Nat Prod 74(4):866–870Google Scholar
  155. 155.
    Bose A, Baral R (2007) Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12. Hum Immunol 68(10):823–831Google Scholar
  156. 156.
    Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, Sharmila G, Arunakaran J (2012) Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol Lett 215(2):131–142Google Scholar
  157. 157.
    Schumacher M, Cerella C, Reuter S, Dicato M, Diederich M (2011) Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica) leaf extract are mediated via modulation of the nuclear factor-κB pathway. Genes Nutr 6(2):149–160Google Scholar
  158. 158.
    Vasenwala SM, Seth R, Haider N, Islam N, Khan T, Maheshwari V, Ur Rehman SA (2012) Study on antioxidant and apoptotic effect of Azadirachta Indica (neem) in cases of cervical cancer. Arch Gynecol Obstet 286(5):1255–1259Google Scholar
  159. 159.
    Govindarajan R, Vijayakumar M, Pushpangadan P (2005) Antioxidant approach to disease management and the role of ‘Rasayana’ herbs of ayurveda. J Ethnopharmacol 99(2):165–178Google Scholar
  160. 160.
    Craig WJ (1997) Phytochemicals: guardians of our health. J Am Diet Assoc 97(10 Suppl 2): S199–S204Google Scholar
  161. 161.
    Xu T, Beelman RB, Lambert JD (2012) The cancer preventive effects of edible mushrooms. Anticancer Agents Med Chem 12(10):1255–1263Google Scholar
  162. 162.
    Scott EN, Gescher AJ, Steward WP, Brown K (2009) Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res 2:525–50Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.School of Animal & Range Sciences, College of Agriculture & Environmental SciencesHaramaya UniversityDire DawaEthiopia

Personalised recommendations